PISCATAWAY, N.J.--An active ingredient found in the oil of the
Southeast Asian croton
plant--12-O-tetradecanoylphorbol-13-acetate, generally known as
TPA--may inhibit the growth of new prostate cancer cells,
according to researchers at Rutgers University.
"We demonstrated TPA could simultaneously stop the growth of new
prostate cancer cells, kill existing cancer cells and ultimately
shrink prostate tumors," said Allan Conney, Ph.D., one of the
study's authors. The researchers also tested the effect of TPA
in combination with all-trans retinoic acid (ATRA), a vitamin A
derivative that has been proved to effectively treat leukemia.
Mice with induced prostate tumors received a daily dose of TPA,
ATRA or a combination of the two for 46 days. After 21 days of
treatment, tumor regression became apparent in 62 percent of
mice treated with TPA, compared to 31 percent of mice treated
with ATRA. All mice receiving the combination treatment showed
signs of tumor regression. Researchers also found TPA and the
combination treatment continued to inhibit tumor growth for the
duration of the study, compared to ATRA inhibiting tumor growth
only for the first 28 days of treatment.
"Our studies are an important early step in a long process, and
we are planning additional testing in humans," Conney said.
"Further research with these compounds and others could provide
hope for the half million new cases of prostate cancer each
year."
The study is published in the March issue of Cancer Research
(64, 5:1811-20, 2004) ( cancerres.aacrjournals.org).
"These abstracts provided courtesy of Natural Products Industry
Insider, published by Virgo Publishing Inc."
Read more about natural prostate health supplement - Prostacet